2013
DOI: 10.1016/j.bmcl.2013.10.058
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(22 citation statements)
references
References 4 publications
0
19
0
Order By: Relevance
“…It was observed that the presence of a cyclic amine between the carboxylate and the C-5 aryl group enhanced the antibacterial activity and the solubility compared to the derivatives without this group . Further improvement in the PK profile was obtained with the inclusion of an α substituent to the carboxylic acid, which showed enhanced solubility, excellent oral bioavailability, and lower clearance.…”
Section: Dna Gyrase and Topoisomerase IV Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation
“…It was observed that the presence of a cyclic amine between the carboxylate and the C-5 aryl group enhanced the antibacterial activity and the solubility compared to the derivatives without this group . Further improvement in the PK profile was obtained with the inclusion of an α substituent to the carboxylic acid, which showed enhanced solubility, excellent oral bioavailability, and lower clearance.…”
Section: Dna Gyrase and Topoisomerase IV Inhibitorsmentioning
confidence: 99%
“…It was observed that the presence of a cyclic amine between the carboxylate and the C-5 aryl group enhanced the antibacterial activity and the solubility compared to the derivatives without this group. 23 Further improvement in the PK profile was obtained with the inclusion of an α substituent to the carboxylic acid, which showed enhanced solubility, excellent oral bioavailability, and lower clearance. Remarkably, compounds 3a,b had powerful inhibitory activity against S. aureus topoisomerase IV (0.012 and 0.008 μg/mL, respectively), proving their selectivity toward the bacterial isoform without affecting human topoisomerase II.…”
Section: Dna Gyrase and Topoisomerase IVmentioning
confidence: 99%
“…Moreover, the benzothiazole core is a widespread scaffold that has been extensively studied [ 54 , 55 , 56 , 57 , 58 , 59 ] and many derivatives are found to be antimicrobial [ 49 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 ], anticancer [ 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 ], anti-Alzheimer’s [ 92 , 93 ], anti-inflammatory [ 94 , 95 , 96 ], anti-HIV [ 97 , 98 , 99 ] anticonvulsant [ 100 , 101 , 102 ], antioxidant [ 39 , 103 ], anti-tuberculosis [ 104 ...…”
Section: Benzazolesmentioning
confidence: 99%
“…Moreover no cross-resistance was observed caused by the mechanisms responsible for conferring resistance to these antibiotics. Both compounds also showed promising pharmacokinetic profile in rat and mouse [80]. gonorrhoeae.…”
Section: Gyrb and Pare Dual Inhibitorsmentioning
confidence: 88%